Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by rtftech16on May 23, 2016 2:12pm

161 Views

Post# 24897728

RE:Nothing ever happens ...

MUGMODs wrote: Nothing ever happens the same way twice - or exactly the same way twice.
Don't expect this one to be sold off to a high bidder in the future.
This one is going to be a dividend play for the longs...IMO.

I expect share price in 10-15 years above $100 whether or not they sell off to the highest bidder.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?